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Abstract
The aim was to determine the predictive role of combined screening for late-onset gestational hypertension by fetal ultrasound
measurements, third trimester uterine arteries (UtAs) Doppler imaging, and maternal history. This prospective study on singleton
pregnancies was conducted at the tertiary center of Maternal and Fetal Medicine of the University of Padua during the period between
January 2012 and December 2014. Ultrasound examination (fetal biometry, fetal wellbeing, maternal Doppler study, fetal abdominal
aorta intima-media thickness [aIMT], and fetal kidney volumes), clinical data (mother age, prepregnancy body mass index [BMI], and
parity), and pregnancy outcomes were collected. The P value <0.05 was deﬁned signiﬁcant considering a 2-sided alternative
hypothesis. The distribution normality of variables were assessed using Kolmogorov–Smirnoff test. Data were presented by mean
(±standard deviation), median and interquartile range, or percentage and absolute values. We considered data from 1381 ultrasound
examinations at 29 to 32 weeks’ gestation, and in 73 cases late gestational hypertension developed after 34 weeks’ gestation. The
ﬁnal multivariate model found that fetal aIMT as well as fetal umbilical artery pulsatility index (PI), maternal age, maternal prepregnacy
BMI, parity, and mean PI of maternal UtAs, assessed at ultrasound examination of 29 to 32 weeks’ gestation, were signiﬁcant and
independent predictors for the development of gestational hypertension after 34 weeks’ gestation. The area under the curve of the
model was 81.07% (95% conﬁdence interval, 75.83%–86.32%). A nomogram was developed starting from multivariate logistic
regression coefﬁcients. Late-gestational hypertension could be independently predicted by fetal aIMT assessment at 29 to 32 weeks’
gestation, ultrasound Doppler waveforms, and maternal clinical parameters.
Abbreviations: aIMT = aorta intima-media thickness, AUC = area under the curve, BMI = body mass index, CI = conﬁdence
interval, HDP = hypertensive disorders of pregnancy, IUGR = intrauterine growth restriction, LGA = large for gestational age, PI =
pulsatility index, RI = resistance index, sFlt-1 = soluble fms-like tyrosine kinase-1, SGA = small for gestational age, UtA = uterine
artery.
Keywords: fetal abdominal aorta intima-media thickness, late-gestational hypertension, predictive markers1. Introduction
The hypertensive disorders of pregnancy (HDP) account for a
signiﬁcant number of maternal and fetal deaths worldwide,
affecting about 5% to 7% of pregnancies considered to be low
risk and of which incidence reaches up to 20% in high-risk
pregnancies. Late onset after 34 weeks’ gestation represents 5%
to 17% of these.[1] Despite the low prevalence of HDP, they
are associated with a signiﬁcant fetal neonatal and maternalEditor: Yutang Wang.
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1mortality and morbidity, including an increased risk of maternal
hypertension in later life.[2,3] The syndrome etiology remains
unclear. The most widely accepted theory postulates that a
defective process of trophoblastic invasion in the uterine spiral
arteries creates a localized hypoxic environment, having as
physiological response the release of several factors that are
hazardous to the systemic vascular endothelium, including
reactive oxygen species, which have a harmful effect on the
mother’s systemic arterial endothelium.[4]
In recently published studies, an increased prevalence of signs of
vascular damage in fetuses from pregnancies affected by
preeclampsia or late-onset HDP emerged; aorta intima-media
thickness (aIMT) was signiﬁcantly increased in fetuses whose
mothers developed HDP, in particular at 29 to 32 weeks’
gestation.[5,6] Gestational hypertension should be considered as
one of the adverse early risk factors that might predispose to an
impaired fetal endothelial development during intrauterine life and
cardiovascular events during adulthood. Nowadays, aIMT is a
feasible, accurate, and sensitive marker of vascular remodeling,
both in fetuses and children. When thicker, aIMT might be the
result of poor intrauterine environment, as described in presence of
intrauterine growth restriction (IUGR).[5] Although several risk
factors for preeclampsia have been recognized, individually they
perform poorly from a screening perspective with a low positive
predictive value.[7,8] There is evidence that late-onset HDP
compared with early-onset disease is more likely to be considered
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metabolic imbalance, resulting in the deterioration of placental
function closer to term.[9–11] An abnormal uterine artery (UtA)
Doppler velocimetry persistent fromsecond trimester up to at 29 to
32 weeks’ gestation is considered to be a surrogate marker of
chronic uteroplacental ischemia and an arise of umbilical artery
(UA) pulsatility index (PI) a sign of fetal compromise.[12]
The aim of this study was to investigate the prediction of late-
onset gestational hypertension by fetal ultrasoundmeasurements,
including aIMT, mean UtA PI, and maternal data collected
during scan examination at 29 to 32 weeks’ gestation.2. Materials and methods
This was a prospective observational study for late gestational
hypertension carried out between January 2012 and December
2014 among patients attending for antenatal care at the
University Hospital of Padua (tertiary referral center). We
included in the study all singleton pregnancies that delivered in
the University Clinic and performed a third trimester hospital
scan to assess fetal growth, maternal–fetal Doppler evaluation,
and fetal aorta intima media thickness assessment. Delivery
before 34 weeks’ gestation, prepregnancy hypertensive disorders,
HDP disorders diagnosed before the 34th week gestation, IUGR
condition (deﬁned by fetal weight below the 10th percentile, fetal
abdominal circumference below the 10th percentile, or third
trimester ﬂattening of the growth curve with UA Doppler
alterations, as PI>2 standard deviation),[13] cholestasis, hemo-
lysis, elevated liver enzymes, low platelet count syndrome,
pregestational diabetes, gestational diabetes, multiple pregnan-
cies, major fetal congenital anomalies, pregnancies complicated
by maternal history of cardiovascular disease or endocrine
disorders such as thyroid and adrenal problems, severe obesity,
and clinical chorioamnionitis were considered as exclusion
criteria. The ethical committee of the hospital approved the study
(P1826, in 2009). Furthermore, the present study was conducted
in accordance with Helsinki Declaration, and written consent
was obtained from the patients.
In June 2015, all the considered patients had delivered.
Information about personal, obstetrical, and familial history
were collected. In addition, demographic data (age, ethnicity, and
parity), lifestyle variables (diet, physical activity, blood pressure,
smoking, use of alcohol, or drugs), and risk factors for several
diseases (obesity, diabetes mellitus, thrombophilia, HDP, preterm
delivery, and IUGR) were also entered into a computer database.
Further information about hospitalization and delivery (e.g.,
development of late hypertension, gestational age at delivery,
mode of delivery, and neonatal data) were gathered from hospital
maternity records. Patients affected by HDP were treated using
methyldopa or nifedipine.
Twenty patients took part in another study about cardiovas-
cular and renal risk in fetuses of HDP.[5] Gestational age was
calculated starting from the last known menstrual period and
conﬁrmed by ultrasound dating before 20 weeks of gestation.
Bodymass index (BMI) was calculated (kg/m2) after measuring
maternal height and weight. Maternal blood pressure was
measured as previously described using an automated device
(Myndraj Biomedical Elettronics IMP/9800, Burnaby, British
Columbia, Canada).[5] The women were in the seated position,
their arms were supported at the level of the heart, using an adult
cuff depending on the mid-arm circumference. We calculated
the mean arterial pressure as the average of the last 3 stable
measurements.[14]2The deﬁnitions of gestational hypertension and preeclampsia
were those of the International Society for the Study of
Hypertension in Pregnancy. In gestational hypertension, the
systolic blood pressure should be 140mm Hg or more and the
diastolic blood pressure should be 90mm Hg or more on at least
2 occasions 4 hours apart, developing after 20 weeks of gestation
in previously normotensive women in the absence of signiﬁcant
proteinuria. In preeclampsia, there should be gestational
hypertension with proteinuria of 300mg or more in 24 hours,
or 2 readings of at least ++ on dipstick analysis of midstream or
catheter urine specimens if no 24-hour collection is available.[15]
For the present study, we considered small for gestational
age (SGA) the newborns with a birth weight less than the
10th percentile. All infants with a birth weight above the 90th
percentile according to gestational age were considered large for
gestational age (LGA).[16]2.1. Ultrasonographic examination
Two skilled operators (SV and EC) performed all the ultrasound
scans using an ultrasound machine equipped with a 3.5- to
5-MHz linear array transducer (Voluson E8, GE Medical
Systems, Chicago, IL, USA).
During the examination at 29 to 32 weeks’ gestation, fetal
growth, fetal wellbeing, and maternal Doppler evaluation were
assessed. The following fetal abdominal aorta characteristics
were considered: fetal aIMT, fetal abdominal aorta diameter, and
abdominal aorta PI. In addition, other ultrasound measurements
were considered: UA PI, middle cerebral artery PI, kidneys’mean
volume, mean maternal UtA PI, mean UtA resistance index (RI),
and the presence of bilateral notching of the UtAs. Fetal renal
volumes were calculated by means of the following ellipsoid
approximation formula: volume= lengthwidth thickness
0.5233.[5,17] The average volume of the 2 kidneys was used,
and the volume percentile was calculated according to previous
published charts.[18]
Intima-media thickness and diameter were measured in a
coronal or sagittal view of the fetus at the dorsal arterial wall of
the most distal 15mm of the abdominal aorta sampled below the
renal arteries and above the iliac arteries as previously described;
gain settings were used to optimize image quality. Abdominal
aIMT was deﬁned as the distance between the leading edge of the
blood–intima interface and the leading edge of the media–-
adventitia interface on the far wall of the vessel. These
measurements were taken, and the arithmetic mean aIMT aortic
intima media thickness was considered for the study. Aortic
diameter was measured at the same level of aIMT, from inner
wall to thewall edges. All images were taken at end-diastole of the
cardiac cycle to minimize the variability. End-diastole was
determined using the cine-loop capability of the ultrasound
machine once the images of the entire cardiac cycle were frozen.
An angle as close as possible to 0 was achieved between the
Doppler ultrasound beam and the direction of blood ﬂow in each
vessel. The high-pass ﬁlter was set at 100Hz.[19]
The aIMT intraobserver and interobserver agreements were
previously assessed and found to be both greater than 0.85.[5,19]
Furthermore, the aIMT images were saved and then analyzed
also off-line by a speciﬁc software, that was previously found
to signiﬁcantly correlate with manual measurements with a
coefﬁcient of 0.9.[20] All manual measurements of the present
study were conﬁrmed by this off-line automated wall tracking
software.[20] The UAwas evaluated in a free loop of the umbilical
cord. Each measurement was taken during fetal apnea after
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averaged velocities (deﬁned as the area under the velocity spectral
envelope) then were measured using the machine software.[19]
The Doppler velocimetry of UtAs was performed with a convex
probe with 3.5MHz of frequency. Color ﬂow mapping was used
to identify in turn left and right UtAs. The insonation of the
arteries was performed in its proximal third, with a maximal
angle of 60°. The calculation of the PI of the UtAwasmade from a
wave similar to at least other 3 symmetrical waves, and the mean
PI of UtAs was calculated using the simple arithmetic mean
between the PI values of the left and right arteries. Protodiastolic
notch in uterine Doppler waveformwas also recorded at the scan.
We deﬁned as abnormal Doppler velocimetry a mean UtA PI>
95th percentile as well as the presence of bilateral notching, and
they reﬂect the higher amount of impedance to blood ﬂow distal
to the UtA.[5,21] All measurements were performed with the
mothers in a semirecumbent position and when there were no
fetal gross body or chest movements.2.2. Outcome measures
The primary outcome was considered the development of late-
onset HDP with or without proteinuria. The secondary outcome
was the role of fetal aIMT in the prediction of late HDP.2.3. Sample size calculation and statistical analysis
The R program (version 3.1.2, R Foundation for Statistical
Computing, Vienna, Austria, http://www.R-project.org/) was
used to analyze the collected data. The present study was done
according to TRIPOD statement.[22] The target sample size was
at least of 38 subjects per group and 76 subjects in total.
According to previous published data, this sample size is
sufﬁcient to detect differences in mean aIMT of 0.15 between
controls and cases, with a standard deviation of 0.2, 5%
signiﬁcant level, and power of 90%.[5] The P value <0.05 was
deﬁned as signiﬁcant considering a 2-sided alternative hypothe-
sis. The distribution normality of variables was assessed using
Kolmogorov–Smirnoff test. Data were presented by mean
(±standard deviation), median and interquartile range, or
percentage and absolute values. In addition, odds ratio and
95% conﬁdence interval (CI) or a speciﬁed reference value (e.g.,
area under the curve [AUC]) and 95% CI were also used. During
the analysis, we used the following statistical tests: in case ofTable 1
Population characteristics.
Late gestational hypertension
Age, y 35.2 (±7.23)
BMI, kg/m2 26.2 (±4.3)
Nulliparity 79.5% (58/73)
Systolic blood pressure, mm Hg 155 (148–161)
Diastolic blood pressure, mm Hg 98 (92–110)
Mode of delivery
Spontaneous vaginal delivery 41.1% (30/73)
Operative vaginal delivery 6.8% (5/73)
Cesarean section 52.1% (38/73)
Gestational age at delivery, wk 36.9 (±1.49)
Neonatal weight, g 3006.3 (±703.62)
Neonatal weight, percentile 51.7 (±39.05)
Apgar score at ﬁrst minute 9.1 (±0.7)
Apgar score at ﬁfth minute 9.8 (±0.45)
The data are expressed as mean and standard deviation (Student t test) or percentage and absolute va
3continuous variables, Student t test or Wilcoxon test; in case of
categorical variables, Fisher exact test or chi-square where
appropriate. Univariate and multivariate logistic regression
analyses were also performed. In the multivariate logistic
regression model, the development of HDP after the 34th
gestational week was considered as the dependent variable,
whereas fetal abdominal aorta characteristics and the other
possible predictive factors were considered as independent
variables. Then, in the multivariate model, all potentially
inﬂuencing factors and their interactions were accommodated
in a single analysis, except when the interaction term was
nonsigniﬁcant (in which case we analyzed the no-interaction
model). Furthermore, we included in the initial multivariate
model all the factors that had a P value <0.200 in univariate
analysis and then performed a stepwise selection to obtain the
ﬁnal multivariate logistic regression model. In addition, model
performance was assessed by the area under the receiver operator
curve with the relative 95% CI. Bonferroni correction was
applied to multivariate analysis. Using the multivariate logistic
regression model, a nomogram was developed as a prognostic
scoring system incorporating signiﬁcant ultrasound and clinical
variables including fetal abdominal aorta data available at
ultrasound examination of 29 to 32 weeks’ gestation. Points for
variables in the nomogram were determined by their logistic
regression model coefﬁcients. In addition, also a risk calculator
based on the same logistic regression model coefﬁcients was
made. Thereafter, a nomogram calibration plot was drawn using
the same regression coefﬁcients of multivariate logistic model and
1000 boot strap repetitions to implement internal validation of
our nomogram.
3. Results
During the study period, 1538 singleton pregnant women
underwent ultrasound examination at 29 to 32 weeks’ gestation.
A total of 1381 pregnancies were included in the study, while 157
were excluded because they presented with at least one of the
exclusion criterion. Seventy-eight patients presented a preterm
delivery. In 73 cases, a diagnosis of HDP after 34weeks’ gestation
was made, while in 1381 cases the pregnancy was regular.
In Table 1, the characteristics of the studied population are
described. Women affected by late-onset HDP were older, with a
higher BMI, and more frequent nulliparous. The blood pressure
of cases was higher than the controls (P<0.05). Moreover,(n=73) Controls (n=1308) P
31.5 (±5.48) <0.05
25.1 (±3.98) <0.05
53.9% (705/1308) <0.05
128 (120–132) <0.05
82 (74–86) 0.02
73.2% (958/1308) <0.05
1.5% (20/1308) <0.05
25.2% (330/1308) <0.05
38.3 (±2.31) <0.05
3170.6 (±529.85) 0.05
51.6 (±23.19) 0.97
9.03 (±0.32) 0.63
9.8 (±0.47) 0.67
lues (Chi-square test). BMI = body mass index.
Table 2
Ultrasound examination at 29 to 32 weeks’ gestation.
Late gestational hypertension (n=73) Controls (n=1308) P
Gestational age at examination, wk 30.5 (±2) 30.9 (±1.17) 0.11
Estimated fetal weight, g 1693.7 (±503.48) 1756.9 (±325.79) 0.33
Estimated fetal weight, percentile 49.2 (±32.77) 50.5 (±29.52) 0.76
Mean kidney volume, mm3 8503.9 (±2618.24) 9989.5 (±2921.55) <0.05
Mean kidney volume, percentile 58.7 (±35.16) 75.1 (±28.59) <0.05
aIMT, mm 0.59 (±0.13) 0.55 (±0.16) <0.05
Aorta diameter, mm 3.6 (±0.80) 3.8 (±0.65) 0.15
PI fetal abdominal aorta 1.26 (±0.28) 1.20 (±0.24) 0.07
PI umbilical artery 1.05 (±0.21) 0.95 (±0.17) <0.05
PI fetal median cerebral artery 2.05 (±0.36) 2.08 (±0.37) 0.66
Mean PI of maternal UtAs 0.88 (±0.46) 0.73 (±0.22) <0.05
Mean RI of maternal UtAs 0.50 (±0.11) 0.47 (±0.10) <0.05
Presence of bilateral notch in UtA 2.7% (2/73) 0.5% (6/1308) 0.06
The data are expressed as mean and standard deviation (Student t test) or percentage and absolute values (Fisher exact test). aIMT = aortic intima-media thickness, PI = pulsatility index, RI = resistance index,
UtAs = uterine arteries.
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cesarean section than controls (P<0.05). Notwithstanding,
mean neonatal weight was lower in the late-onset HDP group,
the neonatal weight percentiles were similar and not signiﬁcantly
different (P=0.97). However, in the group of women affected by
late-onset HDP, there was an increased prevalence of SGA
(37.0%, 27/73) in comparison with 8.7% of controls (114/1308)
(P<0.05). Furthermore, we also found a nonsigniﬁcant increase
in the prevalence of LGA in the group of patients affected byHDP
(P=0.08). Table 2 shows the data relative to the ultrasound
examination performed at 29 to 32 weeks’ gestation. In the HDP
group, we found an increased aIMT, fetal abdominal aorta PI,
UA PI, maternal UtA mean PI, maternal UtA mean RI, and
prevalence of bilateral notch in UtAs. Likewise, we found also a
decreased mean kidney volume (Table 2).
Table 3 explains the univariate and multivariate logistic
regression analyses. After stepwise selection, the following
variables were included in the ﬁnal model: maternal age,
prepregnancy BMI, nulliparity, aIMT, UA PI, andmeanmaternal
UtA PI. In particular, increased maternal age, nulliparity,
increased aIMT, increased UA PI, and mean PI of maternal
UtAs were signiﬁcant risk factors for late HDP development (P<
0.05). Moreover, the multivariate model intercept was 19.73.Table 3
Univariate and multivariate logistic regression analysis.
OR (95% CI)
Age, y 1.15 (1.09–1.2)
BMI, kg/m2 1.06 (0.99–1.13)
Nulliparity 3.77 (1.99–7.15)
Estimated fetal weight, percentile 0.99 (0.99–1.01)
Mean kidney volume, percentile 0.99 (0.98–0.99)
aIMT, mm 5.32 (1.32–21.47)
Aorta diameter, mm 0.95 (0.65–1.38)
PI fetal abdominal aorta 11.73 (3.52–38.72)
PI umbilical artery 34.77 (4.77–253.61)
PI fetal median cerebral artery 0.92 (0.26–3.31)
Mean PI of maternal UtA 2.16 (0.87–5.38)
Mean RI of maternal UtA 3.52 (0.37–33.08)
Presence of UtA bilateral notch 6.41 (1.27–32.44)
aIMT = aortic intima-media thickness, BMI = body mass index, CI = conﬁdence interval, OR = odds
∗
Final multivariate model after stepwise selection, the area under the receiver operator curve was 86.5
† Bonferroni correction was applied to P values.
4Figure 1 represents the developed nomogram, and in the
supplementary ﬁle we prepared a risk calculator, http://links.
lww.com/MD/B504. Figure 2 shows the receiver operator
characteristic curve of the ﬁnal multivariate logistic model that
presented an AUC of 81.07% (95% CI, 75.83%–86.32%).
Considering the included factors in the multivariate logistic
regression model, the AUC values were for maternal age 65.85%
(95% CI, 57.4%–74.29%), for prepregnancy BMI 59.99%
(95% CI, 51.32%–68.66%), for nulliparity 63.99% (95% CI,
58.9%–69.08%), for aIMT 60.65% (95% CI, 54.37%–
66.94%), for UA PI 63.77% (95% CI, 56.56%–70.99%), and
for mean UtA PI 52.13% (95% CI, 43.00%–61.27%).
Internal validation of the prediction nomogramwas performed
using 1000 bootstrap resamples and showed satisfactory
predictive ability for our model (Supplemental ﬁgure 1, http://
links.lww.com/MD/B505).4. Discussion
Hypertensive disorders during pregnancy are a major cause of
maternal and fetal morbidity and mortality. However, an
effective prediction and monitoring might reduce fetal and
maternal morbidities. The study found that fetal aIMT as well asP OR (95% CI)
∗
P†
<0.05 1.21 (1.14–1.29) <0.05
0.07 1.12 (1.04–1.19) <0.05
<0.05 6.23 (3.12–12.45) <0.05
0.74
<0.05
<0.05 10.01 (2.18–46.05) <0.05
0.79
<0.05
<0.05 50.68 (6.07–422.96) <0.05
0.90
0.09 3.28 (1.33–8.14) <0.05
0.27
<0.05
ratio, PI = pulsatility index, RI = resistance index, UtAs = uterine arteries.
0% (95% CI 82.31%–90.69%).
[5,19,23–27]
Figure 1. Nomogram for estimating the probability of late gestational hypertension development at ultrasound examination of 29 to 32 weeks’ gestation by fetal
abdominal aorta biometry, maternal fetal Doppler, fetal biometry, and clinical data. Instructions for reading the nomogram: locate the age of the pregnant women on
the woman’s age axis, then draw a straight line up to the points axis to determine how many points the patient receives for age. Repeat the process for all other
predictors. Thereafter, sum the points achieved for each predictor and locate this sum on the total points axis at the bottom of the plot. Finally, draw down a line
straight to the probability of late gestational hypertension development axis. This plot will also highlight the variables with the greatest discriminatory value that are
those with the widest point range in the nomogram (refer to Supplemental ﬁle 1 for excel sheet version, http://links.lww.com/MD/B504).
Visentin et al. Medicine (2017) 96:2 www.md-journal.comfetal UA PI, maternal age, maternal prepregnancy BMI, parity,
and mean PI of maternal UtAs assessed at ultrasound examina-
tion of 29 to 32 weeks’ gestation are signiﬁcant and independent
predictors for the development of HDP after 34 weeks’ gestation.
In previous studies, ultrasound-based measurement of aIMT in
fetuses of mothers with late-onset HDP and IUGR fetuses seem to
represent a sign of in utero preclinical endothelial remodeling.
Therefore, it possibly might result in subsequent glomeruloscle-
rosis, hypertension in young children, and atherosclerosis in adultFigure 2. Receiver operator characteristics curve with conﬁdence interval bars
of the ﬁnal multivariate logistic regression model (area under the curve was
81.07%, and the 95% conﬁdence interval was 75.83%–86.32%).
5life. These fetal features are in accordance with the
Barker hypothesis that suggests an in utero imprinting that
predisposes to the development of chronic diseases in later life.[28]
Furthermore, in this study, we demonstrated a usefulness of fetal
aIMT assessed at the 29 to 32 weeks’ gestation ultrasound
examination to forecast the development of late-onset HDP after
34 weeks’ gestation. In addition, a higher mean PI and RI with a
bilateral notch of UtAs at the third trimester scan are known to be
signs of placental dysfunction.[5] Women at risk of adverse
pregnancy outcomes are generally identiﬁed based on their
clinical history.[29] Screening bymaternal history alone will detect
a third of women who will develop HDP, but is ineffective in
nulliparous women, who are at particular risk of this complica-
tion. Multiple biochemical markers have been studied individu-
ally and in combination as potential markers for adverse
pregnancy outcomes.[30]
Algorithms combining maternal demographic characteristics
as well as medical and obstetric history together with biophysical
and biochemical markers at 30 to 34 weeks’ gestation have been
developed for the prediction of adverse pregnancy
outcomes.[31–34] In our study, we aimed to assess the develop-
ment of HDP arising after 34 weeks’ gestation by collating
information collected at 29 to 32 weeks’ gestation ultrasound
scan, including aIMT measurement that was never considered
until now for such prediction algorithms.
The ﬁnal multivariate model presented in this study that
considers as predictors fetal aIMT, fetal UA PI, maternal age,
maternal prepregnancy BMI, parity, and mean PI of maternal
UtAs in the development data presented an AUC of 81.07%
(95% CI, 75.83%–86.32%). In addition, in this model, the
detection rate, at 10% false positive rate, was 57.1% for late
HDP (Fig. 2). Despite the low speciﬁcity of this prediction model,
it is easy to implement a prediction method based on clinical
information and ultrasound examination assessment. A different
maternal and fetal concentration of soluble fms-like tyrosine
kinase-1 (sFlt-1) and vascular endothelial growth factor has been
[4] Roberts JM, Gammill HS. Preeclampsia: recent insights. Hypertension
Visentin et al. Medicine (2017) 96:2 Medicinedescribed in presence of hypertensive disorders, leading to
endothelial dysfunction, hypertension, and proteinuria in animal
models.[35,36] According to these results, fetal aIMT could be the
vascular sign of biochemical imbalance and placental insufﬁcien-
cy, and might be considered in more studies on late HDP
prediction with ultrasound examination parameters. In previous
published studies, about third-trimester screening of pregnancies
complications and adverse perinatal events, sFlt-1 was considered
but aIMT never before.[32–34,37,38] The validated models all
included UtA Doppler measures or biomarkers that require
laboratory testing that is not currently part of routine practice
and is too expensive for use in low- or middle-income
countries.[39]
Therefore, in previous studies, the detection rate, at 10% false
positive rate, was 75% for term pre-eclampsia,[33,34] while in our
study it was 57.1%. However, in contrast to other studies, the
ultrasound predictors in this study were assessed earlier, thus at
29 to 32 weeks’ gestation and not at 30 to 34 weeks’
gestation,[32–34,37,38] and it is known that it is easier to predict
the negative outcomes closer to the time when the predictors have
been assessed.[40] Therefore, the low detection rate at 10% false
positive rate was probably partly due to the early assessment of
predictors than in previously published studies.
The main limitation of the study is the unavailability of a
second population to validate the model, although an internal
validation was performed. Among the strengths of this study, we
have a prospective collection of data and the assessment of fetal
aIMT for the ﬁrst time as predictor for late-onset HDP.
5. Conclusion and implications
Current clinical opinion considers mothers presenting with mild-
to-moderate hypertension to have obstetric outcomes not
signiﬁcantly different from those of the normal population.
However, information regarding the long-term outcomes of
pregnancies complicated by mild-to-moderate maternal hyper-
tension is sparse. The potential clinical use of the present model is
to assess the risk of late HDP development at 29 to 30 weeks’
gestation ultrasound examination, in order to select and closely
monitor high-risk pregnancies. The usefulness of selecting high-
risk women for late HDP development resides in the possibility to
intensively monitor maternal and fetal wellbeing of a selected
group of pregnancies to allow an earlier diagnosis for mitigating
eventual adverse outcomes by means of medical induction of
labor.[12] However, this preliminary model needs to be validated
in other populations and improved by future studies in the second
trimester of pregnancy and also during childhood. The fetal
parameter aIMT has for the ﬁrst time a role in a predictive model
for gestational hypertension. In addition, fetal aIMT in future
studies should be considered for implementing routine ultra-
sound examinations as a possible predictor for maternal and fetal
outcomes, mainly because it can be considered an early sign of
fetal endothelial remodeling.[5,19]References
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